Category
Library
Date
Duration
10 min
Company naming is the process of finding a name that triggers the right positioning in the right audience. It requires prior strategy, legal availability analysis and external validation. Choosing a name without these prior steps increases the risk of forced rebranding and intellectual property conflicts.
They all start with the name. Almost all of them get it wrong.
The first impulse of any founder is to christen their project. It makes sense: the name makes real what until then was an idea floating around in a Google Slides presentation. The problem is not wanting a name. The problem is choosing it before knowing what position you want to occupy.
This happens in both seed-stage startups and healthtech projects that have been in the laboratory for years. Company naming is treated as a starting point when, in reality, it closes a process. Putting it at the beginning forces two equally bad scenarios: either reconstructing the name when the project already has traction — and that hurts, both in time and money — or carrying a name that does not fit and building on crooked foundations.
The cost is not only financial. The wrong name creates inconsistency in the narrative, friction in pitches and noise in communication with investors, referrers or clients. All of that has a price, even if it does not appear on any invoice.
What has to exist before the name exists?
Three elements must be resolved before opening any naming tool, automatic generator or brainstorming document:
Positioning. What specific place you want to occupy in the mind of your audience. Not "we are innovators in digital health". Something like: "the only remote triage platform designed for primary care in rural settings with low connectivity". If you cannot say it that concretely, the positioning is not resolved.
Archetype or brand attitude. How this brand behaves, not just what it does. A brand that behaves like an explorer generates different names from one that behaves like an institutional reference. The name does not invent the personality: it reflects it.
Primary audience with surgical precision. Not "health professionals". Nor "investors". Something like "medical specialists in oncology who evaluate diagnostic technology in tertiary hospitals". The more diffuse the audience, the more generic the name ends up being — and the harder it is to register.
Without these three elements defined, naming is a shot in the dark. You can get it right, but not by method.
The special case of healthtech and biotech: the name carries more weight than it seems
In regulated sectors, the name is not just a brand. It is an argument for trust before ethics committees, scientific investors and prescribing physicians. A name that sounds good in a technology pitch can generate regulatory friction when it reaches a clinical evaluation table.
The concrete risks in healthtech are threefold. First, confusion with existing clinical terminology: if your name partially coincides with that of a drug, a protocol or a pathology, the problem is immediate. Second, registration availability in multiple jurisdictions: many biotech projects operate from day one with a European or global vocation, and brand availability in the EUIPO does not guarantee the same in the USPTO or in national registries. Third, the credibility filter of the hospital department head: a name that does not sound like what it does — or that sounds like a consumer startup — does not pass that filter without additional investment in explanation.
The naming in healthtech requires specific terminological validation, trademark clearance searches at a European level and consistency with the language of the sector. Without falling into jargon that the patient does not understand. That balance is not resolved with a name generator.
What company naming actually is (and what it is not)
It is not brainstorming pretty words. It is not concatenating Latin roots with technological suffixes and seeing what domain is available. That produces words, not naming.
Naming is the process of finding a signifier that triggers the right meaning in the right audience. A good name simultaneously meets several conditions: it is pronounceable in the target markets, it has no negative connotations in other languages, it is registrable as a trademark, it has viable domain availability and — the hardest part — it communicates something true about the value proposition without needing additional explanation.
That last point is where most fail. A name that needs two sentences of context to be understood is not a name, it is a placeholder waiting for a real name.
There is a figure that illustrates the legal risk of skipping the process well: according to the EUIPO (European Union Intellectual Property Office), more than 40% of trademark applications in Europe are rejected or conflict with previously registered trademarks. Choosing a name without a prior trademark search is not just a process error. It is gambling with real money, yours or your investors'.
The five types of names and when to use each one
Not all names work the same way or in the same context. There are five categories:
Descriptive. They say what they do. Easy to understand, hard to register. High risk of genericity. Example: "Legal Software". Trademark protection is almost impossible.
Evocative. They suggest without describing. Greater creative freedom. They require investment in building meaning, but that investment accumulates in the brand. For seed-stage startups, they offer the best balance between registrability and semantic carrying capacity.
Abstract. No prior meaning. Maximum registrability, maximum positioning effort. They work when there is a budget and time to build the meaning from scratch.
Acronyms. They almost never work as a starting point. Yes, as a result of prior recognition: IBM was already International Business Machines before becoming IBM.
Founder's names. They transfer personal equity to the brand. Useful in sectors where individual credibility matters. The risk is real: if the founder leaves, the brand suffers.
For healthtech and biotech projects, names that combine recognisable scientific roots with a differentiating element generate greater initial trust without needing additional explanation. According to the Nielsen Global Brand-Origin Report, brand names that communicate a clear benefit generate up to 23% more spontaneous recall compared to abstract names without prior brand building. This is not an argument to discard abstract ones, but rather to understand the effort they imply.
The naming process that YouTube tutorials don't sell you
A rigorous process has four phases. None is optional:
Strategic immersion. Positioning, brand territory, analysis of semantic competition in the sector. What names already exist, what meanings are occupied, what territory is available. This is not inspiration: it is research work.
Generation. Volume before criteria. Minimum of 80-100 candidates before evaluating any. Premature filtering kills good options that at first glance seem strange.
Multidimensional filtering. Pronounceability in target markets, legal availability, cultural connotations in other languages, consistency with the brand narrative. Each candidate goes through all the filters, not just the founder's.
Validation. With a real audience, not with the founding team or family members. The founding team has exposure bias: any name they have heard fifty times seems good to them. External validation breaks that bias with data.
The verbal identity of a brand — of which the name is the central element — is built like this, with a process, not with inspiration.
At Crater, naming is always a consequence of strategy. Never its starting point.
Why the pitch deck is not saved by a good name if the brand does not support it
For a startup preparing a round, the name is the first thing the investor sees. But it is not what convinces them.
What convinces them is the consistency between name, narrative, visual identity and value proposition. A powerful name on an inconsistent brand generates distrust, not attraction. Series A investors read the brand as a sign of operational maturity: if communication is inconsistent, they assume execution will be too. They do not say it, but they think it.
Naming is the tip of the iceberg. What is underneath is what matters. And if there is nothing underneath, the iceberg sinks before reaching the pitch. More on this in brand strategy before raising a round.
When it does make sense to start with the name
There is one case in which the name can come before the formal strategy: when the name itself crystallises the concept of positioning.
It happens rarely. But it happens. If the founder has a very precise intuition of the territory they want to occupy and the name captures it exactly, it can work as a strategic anchor from which to build the rest of the brand.
Even in that case, the strategy must validate that the name holds up. Not the other way around. The founder's intuition is a valuable input. It is not a verdict.
What Crater does differently when working on naming
When a client comes to Crater asking for "just the name", the first conversation is about strategy. Not to prolong the project or to justify more hours. But because a name without a strategy is not an investment: it is an expense with an expiry date.
Naming at Crater is part of the brand service, it is not an isolated deliverable. The process integrates audience research, semantic competition analysis, positioning definition and external validation. Only then comes the generation and selection of the name.
The result is a name that can grow with the company. Not one that will have to be changed when the company has traction and changing it costs ten times more.
Frequently asked questions
What is company naming and how is it different from naming a business?
Company naming is a strategic process that combines brand positioning, legal availability analysis and validation with a real audience. Naming a business is choosing something that sounds good. The difference between the two is a forced rebranding two years later: costly, uncomfortable and avoidable with the correct process from the start.
How much does a professional naming process cost?
It depends on the scope and the sector. Naming integrated into a brand strategy project — with research, generation, legal filtering and validation — ranges between 4,000 and 15,000 euros in specialised consultancies. The cost of a rebranding due to failed naming, with visual identity redesign, brand re-registration and asset updates, systematically exceeds that figure. And that is without counting the damage to accumulated recognition.
Can I do the naming myself for my startup?
You can. The main risk is not creativity but exposure bias and legal validation. If you generate the name yourself, require at least two external steps: a clearance search at the EUIPO before falling in love with any option, and validation with people from your target audience who do not know you. Without those two filters, the name is a gamble.
Why is naming in healthtech more complex than in other sectors?
Because the name operates simultaneously in several registers: it must generate trust before ethics committees and scientific investors, be understandable for the patient and not clash with existing clinical terminology. In addition, trademark availability must be verified in multiple jurisdictions from the start. A name that works in Spain may be registered in Germany or have negative connotations in Anglo-Saxon markets.
What kind of name works best for a seed-phase startup?
Evocative names offer the best balance in the early stages: they have greater registrability than descriptive ones and require less investment in building meaning than abstract ones. They do not describe what the company does, but they trigger a coherent association with the brand territory. That association, well worked, becomes a brand asset as the company grows.
If you are choosing a name before having your brand strategy clear, stop. Let's talk first.
